BIOGEN INC. BIIB
출처: SEC EDGAR XBRL companyconcept (10-K) · 통화 USD
검증 ✓ 매출·재무 = SEC EDGAR XBRL companyconcept (10-K) 공시원본 (AI 추정 0) ✓ 재무 신호 = 공시 숫자 계산 (AI 아님)
$3.9B$7.8B$11.6B$15.5B $14.4B 20072025
🏭 사업부 흥망 해부도(성장·고전·철수·실패) 펼쳐보기 →
재무 신호 · 공시 숫자 계산 · AI 아님 · 판정 없음
✦ 흥망사
버튼을 누르면 위 공시 숫자에 근거한 흥망사를 생성합니다 — AI 서술, 예측·투자조언 없음.
▾ 데이터 표 보기
연도 매출영업이익순이익자산부채 FCF 영업이익률 매출 YoY
2007 $3.2B$780M$638M $735M 24.6%
2008 $4.1B$1.2B$783M$8.5B$2.6B $1.3B 29.6% ▲ 29.2%
2009 $4.4B$1.3B$970M$8.6B$2.3B $909M 29.6% ▲ 6.8%
2010 $4.7B$1.2B$1B$8.1B$2.6B $1.5B 26.5% ▲ 7.7%
2011 $5B$1.7B$1.2B$9B$2.6B $1.5B 34.2% ▲ 7.0%
2012 $5.5B$1.9B$1.4B$10.1B$3.2B $1.6B 33.6% ▲ 9.3%
2013 $6.9B$2.5B$1.9B$11.9B$3.2B $2.1B 36.3% ▲ 25.7%
2014 $9.7B$4B$2.9B$14.3B$3.5B $2.7B 40.9% ▲ 40.0%
2015 $10.8B$4.9B$3.5B$19.5B$10.1B $3.3B 45.4% ▲ 10.9%
2016 $11.4B$5.2B$3.7B$22.9B$10.7B $4B 45.0% ▲ 6.4%
2017 $12.3B$5.3B$2.5B$23.7B$11.1B $3.7B 43.6% ▲ 7.2%
2018 $13.5B$5.9B$4.4B$25.3B$12.3B $5.4B 43.8% ▲ 9.6%
2019 $14.4B$7B$5.9B$27.2B$13.9B $6.6B 49.0% ▲ 6.9%
2020 $13.4B$4.6B$4B$24.6B$13.9B $3.8B 33.8% ▼ 6.5%
2021 $11B$2.8B$1.6B$23.9B$12.9B $3.4B 25.9% ▼ 18.3%
2022 $10.2B$3B$24.6B$11.2B $1.1B ▼ 7.4%
2023 $9.8B$1.2B$26.8B$12B $1.3B ▼ 3.3%
2024 $9.7B$1.6B$28B$11.3B $2.7B ▼ 1.6%
2025 $9.9B$1.3B$29.4B$11.2B $2.1B ▲ 2.2%